TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
DNTH

Dianthus Therapeutics Inc.

Healthcare · Biotechnology · —

96.80$ -4.3% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Dianthus Therapeutics Inc. (DNTH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 531 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet DNTH
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
11 54 157 162 162 190 83 179 374 531
11 53 145 150 152 181 82 177 281 409
4.5 52 58 65 58 132 15 132 23 51
4.5 52 143 146 149 177 75 174 275 404
6.3 1.5 5.6 0.5 0.8 0.1
0.3 0.9
0.0 1.0
2.3 4.1 12 20 18 17 9.5 11 22 38
2.3 4.1 10 14 11 11 8.2 9.6 18 31
0.4 0.4 0.3 0.4
1.7 0.2 3.5 2.8 3.8 3.0 1.2 2.6 4.6 9.7
9.0 50 146 141 144 173 74 169 352 493
-9.7 -45 -103 -179 -254 -326 -46 -89 -174 -337
2.2 2.2 2.1 2.3 2.7 3.4 3.7 5.2 33 38

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?